Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 258

Related Citations for PubMed (Select 15120913)

1.

A novel t(2;20)(q35;p12) in embryonal rhabdomyosarcoma.

Ho RH, Johnson J, Dev VG, Whitlock JA.

Cancer Genet Cytogenet. 2004 May;151(1):73-7.

PMID:
15120913
2.

Normal and rearranged PAX3 expression in human rhabdomyosarcoma.

Frascella E, Toffolatti L, Rosolen A.

Cancer Genet Cytogenet. 1998 Apr 15;102(2):104-9.

PMID:
9546061
3.

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Bühlmann P, Niggli FK, Schäfer BW.

Cancer Res. 2004 Aug 15;64(16):5539-45.

4.

Cytogenetic and molecular findings related to rhabdomyosarcoma. An analysis of seven cases.

Gil-Benso R, López-Ginés C, Carda C, López-Guerrero JA, Ferrer J, Pellín-Pérez A, Llombart-Bosch A.

Cancer Genet Cytogenet. 2003 Jul 15;144(2):125-33.

PMID:
12850375
5.

Embryonal rhabdomyosarcoma with a der(16)t(1;16) translocation.

Kapels KM, Nishio J, Zhou M, Qualman SJ, Bridge JA.

Cancer Genet Cytogenet. 2007 Apr 1;174(1):68-73.

PMID:
17350470
6.

Multimodal genetic diagnosis of solid variant alveolar rhabdomyosarcoma.

Cerveira N, Torres L, Ribeiro FR, Henrique R, Pinto A, Bizarro S, Ferreira AM, Lopes C, Teixeira MR.

Cancer Genet Cytogenet. 2005 Dec;163(2):138-43.

PMID:
16337856
7.

Molecular biology of rhabdomyosarcoma.

Gallego Melcón S, Sánchez de Toledo Codina J.

Clin Transl Oncol. 2007 Jul;9(7):415-9. Review.

PMID:
17652054
8.

Detection of PAX3-FKHR and PAX7-FKHR fusion transcripts in rhabdomyosarcoma by reverse transcriptase-polymerase chain reaction using paraffin-embedded tissue.

Chen BF, Chen ML, Liang DC, Huang YW, Liu HC, Chen SH.

Zhonghua Yi Xue Za Zhi (Taipei). 1999 Feb;62(2):86-91.

PMID:
10063718
9.

A novel PAX3 rearrangement in embryonal rhabdomyosarcoma.

Hosoi H, Kakazu N, Konishi E, Tsuchihashi Y, Hada S, Amaya E, Nakabayahi Y, Misawa-Furihata A, Tabata-Maruyama H, Iehara T, Sugimoto T, Yamane H, Yamasaki M, Shiwaku K, Yanagisawa A, Ono M, Tokiwa K, Iwai N, Hashiba M, Abe T, Sawada T.

Cancer Genet Cytogenet. 2009 Mar;189(2):98-104. doi: 10.1016/j.cancergencyto.2008.10.016.

PMID:
19215790
10.

Use of a novel FISH assay on paraffin-embedded tissues as an adjunct to diagnosis of alveolar rhabdomyosarcoma.

Nishio J, Althof PA, Bailey JM, Zhou M, Neff JR, Barr FG, Parham DM, Teot L, Qualman SJ, Bridge JA.

Lab Invest. 2006 Jun;86(6):547-56.

12.

Concomitant amplification and expression of PAX7-FKHR and MYCN in a human rhabdomyosarcoma cell line carrying a cryptic t(1;13)(p36;q14).

Frascella E, Lenzini E, Schafer BW, Brecevic L, Dorigo E, Toffolatti L, Nanni P, De Giovanni C, Rosolen A.

Cancer Genet Cytogenet. 2000 Sep;121(2):139-45.

PMID:
11063797
13.

Detection of the PAX3-FKHR fusion gene in paediatric rhabdomyosarcoma: a reproducible predictor of outcome?

Anderson J, Gordon T, McManus A, Mapp T, Gould S, Kelsey A, McDowell H, Pinkerton R, Shipley J, Pritchard-Jones K; UK Children's Cancer Study Group (UKCCSG) and the UK Cancer Cytogenetics Group.

Br J Cancer. 2001 Sep 14;85(6):831-5.

14.

Recurrent t(2;2) and t(2;8) translocations in rhabdomyosarcoma without the canonical PAX-FOXO1 fuse PAX3 to members of the nuclear receptor transcriptional coactivator family.

Sumegi J, Streblow R, Frayer RW, Dal Cin P, Rosenberg A, Meloni-Ehrig A, Bridge JA.

Genes Chromosomes Cancer. 2010 Mar;49(3):224-36. doi: 10.1002/gcc.20731.

15.

Detection of FOXO1 (FKHR) gene break-apart by fluorescence in situ hybridization in formalin-fixed, paraffin-embedded alveolar rhabdomyosarcomas and its clinicopathologic correlation.

Mehra S, de la Roza G, Tull J, Shrimpton A, Valente A, Zhang S.

Diagn Mol Pathol. 2008 Mar;17(1):14-20. doi: 10.1097/PDM.0b013e3181255e62.

PMID:
18303411
16.

Global gene expression profiling of PAX-FKHR fusion-positive alveolar and PAX-FKHR fusion-negative embryonal rhabdomyosarcomas.

Laé M, Ahn EH, Mercado GE, Chuai S, Edgar M, Pawel BR, Olshen A, Barr FG, Ladanyi M.

J Pathol. 2007 Jun;212(2):143-51.

PMID:
17471488
17.

Translocation (2;8)(q35;q13): a recurrent abnormality in congenital embryonal rhabdomyosarcoma.

Meloni-Ehrig A, Smith B, Zgoda J, Greenberg J, Perdahl-Wallace E, Zaman S, Mowrey P.

Cancer Genet Cytogenet. 2009 May;191(1):43-5. doi: 10.1016/j.cancergencyto.2009.01.010.

PMID:
19389508
18.

Cytogenetic abnormalities in 42 rhabdomyosarcoma: a United Kingdom Cancer Cytogenetics Group Study.

Gordon T, McManus A, Anderson J, Min T, Swansbury J, Pritchard-Jones K, Shipley J; United kingdom Children's Cancer Study Group; United Kingdom Cancer Cytogenetics Group.

Med Pediatr Oncol. 2001 Feb;36(2):259-67.

PMID:
11452933
19.

Detection of the t(2;13)(q35;q14) and PAX3-FKHR fusion in alveolar rhabdomyosarcoma by fluorescence in situ hybridization.

Biegel JA, Nycum LM, Valentine V, Barr FG, Shapiro DN.

Genes Chromosomes Cancer. 1995 Mar;12(3):186-92.

PMID:
7536457
20.

Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.

Onisto M, Slongo ML, Gregnanin L, Gastaldi T, Carli M, Rosolen A.

Int J Oncol. 2005 Sep;27(3):791-8.

PMID:
16077930
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk